---
title: "688105.SH (688105.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688105.SH/news.md"
symbol: "688105.SH"
name: "688105.SH"
parent: "https://longbridge.com/en/quote/688105.SH.md"
datetime: "2026-03-08T06:28:05.174Z"
locales:
  - [en](https://longbridge.com/en/quote/688105.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688105.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688105.SH/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/688105.SH/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688105.SH/news.md)


# 688105.SH (688105.SH) — Related News

### [Vazyme's net loss attributable to shareholders for the year 2025 is 16.9702 million yuan](https://longbridge.com/en/news/277033423.md)
*2026-02-26T11:49:14.000Z*
> Vazyme released its performance preliminary report for 2025, reporting an operating income of 1.378 billion yuan, a net 

### [](https://longbridge.com/en/news/274536080.md)
*2026-02-02T15:46:04.000Z*
> Novo Nordisk: CagriSema shows superior weight loss effects compared to semaglutide

### [](https://longbridge.com/en/news/274536017.md)
*2026-02-02T15:45:59.000Z*
> Novo Nordisk announced the main clinical trial results of Reimagine 2. Novo Cagrisema demonstrated a weight loss effect 

### [Novo Nordisk's Wegovy oral tablet weekly prescription volume exceeds 26,000](https://longbridge.com/en/news/274447445.md)
*2026-02-02T01:53:52.000Z*
> Barclays analysts cited data from IQVIA, indicating that the prescription volume for Novo Nordisk's Wegovy tablets reach

### [Vazyme issued a profit warning, expecting a net loss attributable to the parent company of 10 million to 20 million yuan for the fiscal year 2025](https://longbridge.com/en/news/274139226.md)
*2026-01-29T11:16:02.000Z*
> According to the Zhitong Finance APP, Vazyme announced that the company expects to achieve a net profit attributable to 

### [Ro CEO says Wegovy pill is bringing in new customers, including men](https://longbridge.com/en/news/274000007.md)
*2026-01-28T14:00:00.000Z*
> Telehealth company Ro has seen a surge in customers for the newly launched Wegovy pill, particularly among men. The pill

### [Kingmed Diagnostics has reached a strategic cooperation with Vazyme](https://longbridge.com/en/news/273992804.md)
*2026-01-28T12:59:25.000Z*
> On January 28th, Kingmed Diagnostics officially reached a strategic cooperation with Nanjing Vazyme Biotechnology Co., L

### [3 Asian Stocks That May Be Trading Below Fair Value By Up To 45.1%](https://longbridge.com/en/news/272504124.md)
*2026-01-14T05:50:40.000Z*
> Three Asian stocks identified as potentially undervalued include Anhui Ronds Science & Technology, trading at CN¥50.81 w

### [Vazyme: As of the end of 2023, a total of RMB 2.9997 million shares have been repurchased for incentives](https://longbridge.com/en/news/271412541.md)
*2026-01-04T07:49:37.000Z*
> Vazyme announced that as of December 31, 2025, the company has repurchased a total of 2.9997 million yuan worth of share